Sector practices

Four sectors, in both directions.

A sector practice is not a separate service. It is the evidence that we have run these services before in your category — the regulatory particularities, the buyers, the failure patterns and the published work. Across all four: pharmaceuticals, biotech, medical devices, diagnostics and laboratory tools.

Rare Disease

Orphan pathways, catalogue access, patient associations and the pricing conversation that follows approval.

Rare disease is the category where the regulatory route and the commercial route are least separable. Approval without catalogue access is a certificate; catalogue access without patient identification is a forecast nobody meets. We work the two together, with the associations and the specialist centres that decide whether a patient is ever found.

The Rare Disease practice →

Dental

Clinics, dental service organisations, volume-based procurement and keeping control of brand and price.

Dental is one of the least forgiving markets on the corridor: procurement rounds move price faster than a European head office can react, and the distributor who signs you is often the distributor who decides your positioning. It is also where JUMO has published the most.

The Dental practice →

Consumer Health

Dermocosmetics, cosmetics, food supplements and OTC — where the claim you make decides the channel you can sell in.

Dermocosmetics, cosmetics, food supplements and OTC sit in different regulatory and retail worlds on either side of the corridor. What you are permitted to say determines where you are permitted to sell, which is why claims work comes before brand work and brand work comes before media.

The Consumer Health practice →

Health & Sport

Sport and physical activity as a compliant channel for pharmaceutical companies — disease education, public relations and non-drug intervention.

Direct-to-consumer promotion of a prescription product is prohibited in China and heavily sanctioned in Europe. Sport and physical activity give a pharmaceutical company a legitimate, compliant way to reach a patient population — through disease education, public relations and non-drug intervention rather than through advertising.

The Health and Sport practice →

How a sector meets a service

The method does not change with the category. The gates do.

Every service runs in every sector and in both directions. What the sector changes is which regulator applies, who the buyer is, how price is set and where entries usually fail. Start from the service if you know what you want to buy, and from the sector if you want to know whether we have done it before.